HAEM5:Acute myeloid leukaemia with MECOM rearrangement: Difference between revisions
| [checked revision] | [checked revision] |
No edit summary |
No edit summary |
||
| (2 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
{{DISPLAYTITLE:Acute myeloid leukaemia with MECOM rearrangement}} | {{DISPLAYTITLE:Acute myeloid leukaemia with MECOM rearrangement}} | ||
[[HAEM5:Table_of_Contents|Haematolymphoid Tumours (WHO Classification, 5th ed.)]] | [[HAEM5:Table_of_Contents|Haematolymphoid Tumours (WHO Classification, 5th ed.)]] | ||
{{Under Construction}} | {{Under Construction}} | ||
| Line 13: | Line 13: | ||
Gordana Raca MD PhD, University of Southern California, Los Angeles | Gordana Raca MD PhD, University of Southern California, Los Angeles | ||
==WHO Classification of Disease== | ==WHO Classification of Disease== | ||
| Line 51: | Line 49: | ||
==Gene Rearrangements== | ==Gene Rearrangements== | ||
[[File:inv(3)(q21q26.2).png|inv(3)(q21q26.2)]][[File:t(3;3)(q21;q26.2).png|t(3;3)(q21;q26.2)]] | |||
Put your text here and fill in the table <span style="color:#0070C0">(''Instructions: Details on clinical significance such as prognosis and other important information can be provided in the notes section. Please include references throughout the table. Do not delete the table.'')</span> | Put your text here and fill in the table <span style="color:#0070C0">(''Instructions: Details on clinical significance such as prognosis and other important information can be provided in the notes section. Please include references throughout the table. Do not delete the table.'')</span> | ||